These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 29961792)
1. Proline hydroxylation at different sites in hypoxia-inducible factor 1α modulates its interactions with the von Hippel-Lindau tumor suppressor protein. Qian H; Zou Y; Tang Y; Gong Y; Qian Z; Wei G; Zhang Q Phys Chem Chem Phys; 2018 Jul; 20(27):18756-18765. PubMed ID: 29961792 [TBL] [Abstract][Full Text] [Related]
2. Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von Hippel-Lindau Suppressor. Domene C; Jorgensen C; Vanommeslaeghe K; Schofield CJ; MacKerell A J Chem Theory Comput; 2015 Aug; 11(8):3946-54. PubMed ID: 26574473 [TBL] [Abstract][Full Text] [Related]
3. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway? Minervini G; Masiero A; Moro S; Tosatto SC FEBS Lett; 2013 Sep; 587(18):2996-3001. PubMed ID: 23886708 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. Miller F; Kentsis A; Osman R; Pan ZQ J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064 [TBL] [Abstract][Full Text] [Related]
5. Chemical basis for the selectivity of the von Hippel Lindau tumor suppressor pVHL for prolyl-hydroxylated HIF-1alpha. Illingworth CJ; Loenarz C; Schofield CJ; Domene C Biochemistry; 2010 Aug; 49(32):6936-44. PubMed ID: 20695530 [TBL] [Abstract][Full Text] [Related]
6. Simulation of the mutation F76del on the von Hippel-Lindau tumor suppressor protein: mechanism of the disease and implications for drug development. Limaverde-Sousa G; Barreto Ede A; Ferreira CG; Casali-da-Rocha JC Proteins; 2013 Feb; 81(2):349-63. PubMed ID: 23011899 [TBL] [Abstract][Full Text] [Related]
7. Effects of point mutations in pVHL on the binding of HIF-1α. Domene C; Illingworth CJ Proteins; 2012 Mar; 80(3):733-46. PubMed ID: 22105711 [TBL] [Abstract][Full Text] [Related]
8. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product. Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553 [TBL] [Abstract][Full Text] [Related]
9. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex. Dong X; Su X; Yu J; Liu J; Shi X; Pan Q; Yang J; Chen J; Li L; Cao H J Mol Graph Model; 2017 Jan; 71():116-123. PubMed ID: 27902963 [TBL] [Abstract][Full Text] [Related]
10. Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours. Snell CE; Turley H; McIntyre A; Li D; Masiero M; Schofield CJ; Gatter KC; Harris AL; Pezzella F PLoS One; 2014; 9(2):e88955. PubMed ID: 24563687 [TBL] [Abstract][Full Text] [Related]
11. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592 [TBL] [Abstract][Full Text] [Related]
12. Activation of hypoxia-induced transcription in normoxia. Hägg M; Wennström S Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Metzen E; Zhou J; Jelkmann W; Fandrey J; Brüne B Mol Biol Cell; 2003 Aug; 14(8):3470-81. PubMed ID: 12925778 [TBL] [Abstract][Full Text] [Related]
15. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. Yuan Y; Hilliard G; Ferguson T; Millhorn DE J Biol Chem; 2003 May; 278(18):15911-6. PubMed ID: 12606543 [TBL] [Abstract][Full Text] [Related]
16. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Min JH; Yang H; Ivan M; Gertler F; Kaelin WG; Pavletich NP Science; 2002 Jun; 296(5574):1886-9. PubMed ID: 12004076 [TBL] [Abstract][Full Text] [Related]
17. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Pan Y; Mansfield KD; Bertozzi CC; Rudenko V; Chan DA; Giaccia AJ; Simon MC Mol Cell Biol; 2007 Feb; 27(3):912-25. PubMed ID: 17101781 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Park YK; Ahn DR; Oh M; Lee T; Yang EG; Son M; Park H Mol Pharmacol; 2008 Jul; 74(1):236-45. PubMed ID: 18426857 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Pagé EL; Chan DA; Giaccia AJ; Levine M; Richard DE Mol Biol Cell; 2008 Jan; 19(1):86-94. PubMed ID: 17942596 [TBL] [Abstract][Full Text] [Related]
20. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Chan DA; Sutphin PD; Yen SE; Giaccia AJ Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]